COVID-19 Antibody Responses in Cystic Fibrosis
COVID-19 Antibody Responses in Cystic Fibrosis
Active, not recruiting · NCT05052294 · Registry updated 2025-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| COVID-19 Antibody Responses in Cystic Fibrosis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Active, not recruiting | Not stated | 2025-03-30 | NCT05052294 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brno University Hospital | 31 |
| University Hospital, Motol | 17 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brno University Hospital | Brno | Czechia | 1 |
| University Hospital Motol | Prague | Czechia | 4 |